Literature DB >> 10858202

Low interleukin-12 activity in severe Plasmodium falciparum malaria.

A J Luty1, D J Perkins, B Lell, R Schmidt-Ott, L G Lehman, D Luckner, B Greve, P Matousek, K Herbich, D Schmid, J B Weinberg, P G Kremsner.   

Abstract

We compared interleukin-12 (IL-12) and other cytokine activities during and after an acute clinical episode in a matched-pair case-control study of young African children who presented with either mild or severe Plasmodium falciparum malaria. The acute-phase, pretreatment plasma IL-12 and alpha interferon (IFN-alpha) levels, as well as the acute-phase mitogen-stimulated whole-blood production capacity of IL-12, were significantly lower in children with severe rather than mild malaria. IL-12 levels, in addition, showed strong inverse correlations both with parasitemia and with the numbers of circulating malaria pigment-containing neutrophils. Acute-phase plasma tumor necrosis factor (TNF) and IL-10 levels were significantly higher in those with severe malaria, and the concentrations of both of these cytokines were positively correlated both with parasitemia and with the numbers of pigment-containing phagocytes in the blood. Children with severe anemia had the highest levels of TNF in plasma. In all the children, the levels in plasma and production capacities of all cytokines normalized when they were healthy and parasite free. The results indicate that severe but not mild P. falciparum malaria in young, nonimmune African children is characterized by down-regulated IL-12 activity, contrasting markedly with the up-regulation of both TNF and IL-10 in the same children. A combination of disturbed phagocyte functions resulting from hemozoin consumption, along with reduced IFN-gamma responses, may contribute to these differential effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858202      PMCID: PMC101666          DOI: 10.1128/IAI.68.7.3909-3915.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria.

Authors:  L Hviid; J A Kurtzhals; B Q Goka; J O Oliver-Commey; F K Nkrumah; T G Theander
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Interleukin-12 and malaria.

Authors:  J M Crutcher; M M Stevenson; M Sedegah; S L Hoffman
Journal:  Res Immunol       Date:  1995 Sep-Oct

3.  World malaria situation in 1994. Part I. Population at risk.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-09-05

4.  Malaria pigment in leucocytes.

Authors:  W G Metzger; B G Mordmüller; P G Kremsner
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Nov-Dec       Impact factor: 2.184

5.  Sterile protection of monkeys against malaria after administration of interleukin-12.

Authors:  S L Hoffman; J M Crutcher; S K Puri; A A Ansari; F Villinger; E D Franke; P P Singh; F Finkelman; M K Gately; G P Dutta; M Sedegah
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

6.  Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance.

Authors:  B G Mordmüller; W G Metzger; P Juillard; B M Brinkman; C L Verweij; G E Grau; P G Kremsner
Journal:  Eur Cytokine Netw       Date:  1997-03       Impact factor: 2.737

7.  Malaria epidemiology in the province of Moyen Ogoov, Gabon.

Authors:  E Wildling; S Winkler; P G Kremsner; C Brandts; L Jenne; W H Wernsdorfer
Journal:  Trop Med Parasitol       Date:  1995-06

8.  Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo.

Authors:  B A Sherry; G Alava; K J Tracey; J Martiney; A Cerami; A F Slater
Journal:  J Inflamm       Date:  1995

9.  Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria.

Authors:  M Ho; M M Sexton; P Tongtawe; S Looareesuwan; P Suntharasamai; H K Webster
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

10.  Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production.

Authors:  P G Kremsner; S Winkler; C Brandts; E Wildling; L Jenne; W Graninger; J Prada; U Bienzle; P Juillard; G E Grau
Journal:  Am J Trop Med Hyg       Date:  1995-11       Impact factor: 2.345

View more
  83 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Relationship between plasma Interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya.

Authors:  Sujittra Chaisavaneeyakorn; Caroline Othoro; Ya Ping Shi; Juliana Otieno; Sansanee C Chaiyaroj; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

3.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 4.  Concepts of immunostimulation to increase antiparasitic drug action.

Authors:  K Noel Masihi
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

5.  Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.

Authors:  Collins Ouma; Gregory C Davenport; Steven Garcia; Prakasha Kempaiah; Ateefa Chaudhary; Tom Were; Samuel B Anyona; Evans Raballah; Stephen N Konah; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Hum Genet       Date:  2011-08-05       Impact factor: 4.132

6.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha.

Authors:  Anshuman Sarangi; P C Mohapatra; R K Dalai; Ashok Kumar Sarangi
Journal:  J Parasit Dis       Date:  2013-01-09

Review 8.  Pathogenesis of anemia in malaria: a concise review.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2007-09-16       Impact factor: 2.289

9.  A replication study of the association between the IL12B promoter allele CTCTAA and susceptibility to cerebral malaria in Thai population.

Authors:  Izumi Naka; Jintana Patarapotikul; Katsushi Tokunaga; Hathairad Hananantachai; Naoyuki Tsuchiya; Jun Ohashi
Journal:  Malar J       Date:  2009-12-11       Impact factor: 2.979

Review 10.  Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question.

Authors:  Thiago Castro-Gomes; Luiza C Mourão; Gisely C Melo; Wuelton M Monteiro; Marcus V G Lacerda; Érika M Braga
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.